Subcutaneous nodule after vaccination with an aluminum-containing vaccine.
نویسندگان
چکیده
Persistent subcutaneous nodules may arise after vaccination or allergen desensitization. The swelling might appear as a result of a specific histiocytic reaction to aluminum, which is used in many preparations to hasten immune response. A wide range of such vaccines are used in national childhood vaccination programs. Such nodules are frequently itchy or painful with local skin alterations. The condition tends to resolve spontaneously, although long-term observation is recommended. We describe the clinical history of a 10-year-old girl who presented with an itchy subcutaneous nodule that appeared five months after her second DiTe revaccination.
منابع مشابه
Salmonella enterica serovar Enteritidis live vaccine strain in the reproductive organs of laying goose after subcutaneous vaccination
Serovar-specific real-time PCR for Salmonella enterica serovar Enteritidis (S. Enteritidis) was conductedto detect the genomic DNA of S. Enteritidis from laying goose after subcutaneous vaccination at differenttime points. Indirect fluorescent antibody (IFA) technique and immunohistochemical localization wereemployed to validate the results. The results showed that S. Enteritidis was consistent...
متن کاملUnexpected loss of contact allergy to aluminium induced by vaccine
BACKGROUND In studies in Gothenburg, Sweden, in the 1990s of an aluminium hydroxide-adsorbed pertussis toxoid vaccine, 745 of ~76 000 vaccinated children developed long-lasting itchy subcutaneous nodules at the vaccination site. Of 495 children with itchy nodules patch tested for aluminium allergy, 376 (76%) were positive. OBJECTIVES To study the prognosis of the vaccine-induced aluminium all...
متن کاملAluminum-containing vaccine associated adverse events: role of route of administration and gender.
Anthrax vaccine, adsorbed (AVA) is a vaccine containing aluminum hydroxide that is administered as six subcutaneous (s.q.) doses over 18 months. It is the only aluminum hydroxide licensed for s.q. administration. To optimize the vaccination schedule and route of administration, a prospective pilot study comparing the use of fewer doses administered intramuscularly (i.m.) as well as s.q. with th...
متن کاملAnthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans.
Anthrax vaccine adsorbed (AVA), an effective countermeasure against anthrax, is administered as six subcutaneous (SQ) doses over 18 months. To optimize the vaccination schedule and route of administration, we performed a prospective pilot study comparing the use of fewer AVA doses administered intramuscularly (IM) or SQ with the current schedule and route. We enrolled 173 volunteers, randomized...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Acta dermatovenerologica Alpina, Pannonica, et Adriatica
دوره 17 4 شماره
صفحات -
تاریخ انتشار 2008